Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work building brand new antifungals has acquired a notable boost from the u...

Capricor offers Europe rights to late-stage DMD therapy for $35M

.Having actually scooped up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenne musc...

FDA scraps adcomm for Applied's unusual condition medicine

.After dismissing the decision meeting for Applied Rehabs' metabolic ailment medication govorestat, ...

Novo inks $600M NanoVation offer to analyze hereditary drugs ex-liver

.Novo Nordisk is actually proceeding its own push right into genetic medications, accepting pay Nano...

Innovent web links cytokine to intestines cancer cells responses

.Innovent Biologics has helped make the scenario that its checkpoint inhibitor-cytokine combination ...

Merck, Daiichi ADC hits goal in phase 3 bronchi cancer cells research study

.A phase 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina strengthens AI center with collab to select cancer aim ats

.Five months after Rakovina Therapeutics rotated towards artificial intelligence, the cancer-focused...

Ascendis' dwarfism medication favorites in stage 3, endangers BioMarin

.Ascendis Pharma has actually become a prospective threat to BioMarin's Voxzogo, stating stage 3 gro...

Despite ph. 3 miss out on, Alkeus observes course in advance for eye disease asset

.Though Alkeus Pharmaceuticals' oral eye illness resource stopped working to substantially minimize ...

Kairos goes social along with $6M IPO to finance trials of cancer medication

.With a triad of biotechs reaching the Nasdaq on Friday, it was effortless to overlook a smaller-sca...